113 related articles for article (PubMed ID: 1673585)
1. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
Barnett DB; Lu XY
Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
5. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
Limas CJ; Limas C
J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
[TBL] [Abstract][Full Text] [Related]
6. Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase.
Arnold IR; Mistry R; Barnett DB
Eur J Pharmacol; 1993 May; 245(3):285-9. PubMed ID: 8392940
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
Martin SW; Broadley KJ
Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
[TBL] [Abstract][Full Text] [Related]
9. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
Yabana H; Watanabe H; Narita H; Nagao T
Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
[TBL] [Abstract][Full Text] [Related]
10. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
11. In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase.
Arnold IR; Mistry R; Barnett DB
J Cardiovasc Pharmacol; 1993 Sep; 22(3):481-7. PubMed ID: 7504142
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the beta 1-adrenoceptor stimulatory effects of the partial beta 1-agonists acebutolol, xamoterol, H142/08 and H201/70.
Abrahamsson T
Eur J Pharmacol; 1989 May; 164(1):121-8. PubMed ID: 2568935
[TBL] [Abstract][Full Text] [Related]
13. Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart.
Vigholt Sørensen E; Nielsen-Kudsk F
Eur J Pharmacol; 1986 Jun; 125(3):363-71. PubMed ID: 2874040
[TBL] [Abstract][Full Text] [Related]
14. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
Cheron P; Nannan M; Pouleur H; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
[TBL] [Abstract][Full Text] [Related]
16. Independent regulation of beta 1- and beta 2-adrenoceptors.
Beer M; Hacker S; Poat J; Stahl SM
Br J Pharmacol; 1987 Dec; 92(4):827-34. PubMed ID: 2892556
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic infusion of (-)-isoprenaline on rat cardiac muscarinic (M2)-cholinoceptors and beta 1- and beta 2-adrenoceptors.
Sarsero D; Molenaar P
J Auton Pharmacol; 1995 Aug; 15(4):239-55. PubMed ID: 8576272
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
19. Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
Schäfers RF; Karl I; Mennicke K; Daul AE; Philipp T; Brodde OE
Br J Clin Pharmacol; 1999 Jan; 47(1):59-66. PubMed ID: 10073741
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular actions of xamoterol (ICI 118,587) in anaesthetized cats, rats, and guinea pigs.
Mian MA; Malta E; Raper C
J Cardiovasc Pharmacol; 1986; 8(2):314-23. PubMed ID: 2422470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
